NVCT   $7.59  12.28% Market Closed After Close 7.7 1.45%

Nuvectis Pharma Inc
Total Cash 18.12M
totalCashPerShare 0.971
EBITDA
Total Debt 0.00
quickRatio 3.14
currentRatio 3.171
Total Revenue
debtToEquity
Revenue/Share
ROA -0.60890996
ROE -1.28436
grossProfits
freeCashflow -6.93M
operatingCashflow -14.47M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 104.99M
forwardPE -6.346154
floatShares 6.64M
sharesOutstanding 18.65M
sharesShort 989.58K
sharesShortPriorMonth 924.38K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.11%
Short Ratio help_outline 11.11%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 0.668
Price To Book help_outline 9.88
earningsQuarterlyGrowth
netIncomeToCommon -21.10M
trailingEps -1.29%
forwardEps -1.04%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 55
lastUpdated Oct. 17, 2024, 3:58 a.m.